| Literature DB >> 25436114 |
Mohsen Shahriari Moghadam1, Gholamhossein Ebrahimipour2, Behrooz Abtahi3, Alireza Ghassempour4, Mehri Seyed Hashtroudi5.
Abstract
Polycyclic aromatic hydrocarbons (PAHs) biodegradation in contaminated sediment is an attractive remediation technique and its success depends on the optimal condition for the PAH-degrading isolates. The aims of the current study was to isolate and identify PAHs-degrading bacteria from surface sediments of Nayband Bay and to evaluate the efficiency of statistically based experimental design for the optimization of phenanthrene (Phe) and Fluorene (Flu) biodegradation performed by enriched consortium. PAHs degrading bacteria were isolated from surface sediments. Purified strains were then identified by 16S rDNA gene sequence analysis. Taguchi L16 (4(5)) was employed to evaluate the optimum biodegradation of Phe and Flu by the enriched consortium. Total of six gram-negative bacterial strains including Marinobacter hydrocarbonoclasticus, Roseovarius pacificus, Pseudidiomarina sediminum and 3 unidentified strains were isolated from enrichment consortium, using Fluorene (Flu) and phenanthrene (Phe) as the sole carbon and energy source. The enriched consortium showed highest degradation abilities (64.0% Flu and 58.4% Phe degraded in 7 days) in comparison to a single strain cultures or mixtures. Maximum biodegradation efficiency was occur at temperature = 35°C; pH = 8; inoculum size = 0. 4 OD600nm; salinity = 40 ppt; C/N ratio = 100:10. In conclusion our results showed that, indigenous bacteria from mangrove surface sediments of Nayband Bay have high potential to degrade Flu and Phe with the best results achieved when enriched consortium was used.Entities:
Keywords: Bioremediation; PAHs; Soil contamination; Taguchi experimental design
Year: 2014 PMID: 25436114 PMCID: PMC4243957 DOI: 10.1186/s40201-014-0114-6
Source DB: PubMed Journal: J Environ Health Sci Eng
Combinations of the five factors and four levels on Flu and Phe biodegradation by enriched consortium
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
| pH | 6.5 | 7 | 7.5 | 8 |
| Temperature (°C) | 20 | 25 | 30 | 35 |
| Inoculum size (OD600nm) | 0.05 | 0.1 | 0.2 | 0.4 |
| Salinity (ppt) | 25 | 30 | 35 | 40 |
| Carbon/Nitrogen (molar) | 100:5 | 100:10 | 100:20 | 100:40 |
Experimental conditions for Flu and Phe biodegradation based on the orthogonal design form L (4 ) and results of Flu and Phe biodegradation and first order rate constant (k) at the end of 20-day experiments
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||||
| 1 | 8 | 20 | 25 | 0.05 | 100:5 | 16.26 ± 0.29 | 16.45 ± 3.63 | 0.008 | 0.009 | 0.68 | 0.71 |
| 2 | 8 | 25 | 30 | 0.1 | 100:10 | 66.31 ± 7.02 | 66.07 ± 7.19 | 0.052 | 0.053 | 0.93 | 0.91 |
| 3 | 8 | 30 | 35 | 0.2 | 100:20 | 76.35 ± 5.09 | 77.00 ± 3.00 | 0.070 | 0.070 | 0.91 | 0.90 |
| 4 | 8 | 35 | 40 | 0.4 | 100:40 | 92.18 ± 1.51 | 89.84 ± 3.03 | 0.122 | 0.108 | 0.92 | 0.91 |
| 5 | 7.5 | 20 | 30 | 0.2 | 100:40 | 78.08 ± 5.07 | 73.88 ± 8.20 | 0.080 | 0.072 | 0.98 | 0.98 |
| 6 | 7.5 | 25 | 25 | 0.4 | 100:20 | 77.83 ± 3.50 | 80.59 ± 4.51 | 0.070 | 0.078 | 0.92 | 0.91 |
| 7 | 7.5 | 30 | 40 | 0.05 | 100:10 | 85.68 ± 7.55 | 78.74 ± 4.29 | 0.103 | 0.078 | 0.99 | 0.96 |
| 8 | 7.5 | 35 | 35 | 0.1 | 100:5 | 82.28 ± 6.06 | 77.13 ± 3.72 | 0.089 | 0.075 | 0.96 | 0.97 |
| 9 | 7 | 20 | 35 | 0.4 | 100:10 | 82.16 ± 6.29 | 79.28 ± 5.59 | 0.088 | 0.080 | 0.95 | 0.94 |
| 10 | 7 | 25 | 40 | 0.2 | 100:5 | 83.82 ± 4.48 | 76.53 ± 6.28 | 0.094 | 0.075 | 0.97 | 0.98 |
| 11 | 7 | 30 | 25 | 0.1 | 100:40 | 87.17 ± 4.47 | 80.61 ± 6.60 | 0.105 | 0.084 | 0.99 | 0.99 |
| 12 | 7 | 35 | 30 | 0.5 | 100:20 | 80.38 ± 5.62 | 76.42 ± 6.41 | 0.085 | 0.076 | 0.97 | 0.99 |
| 13 | 6.5 | 20 | 40 | 0.1 | 100:20 | 47.33 ± 4.17 | 46.35 ± 3.80 | 0.032 | 0.032 | 0.96 | 0.97 |
| 14 | 6.5 | 25 | 35 | 0.05 | 100:40 | 42.13 ± 3.18 | 38.71 ± 5.10 | 0.026 | 0.025 | 0.95 | 0.98 |
| 15 | 6.5 | 30 | 30 | 0.4 | 100:5 | 72.55 ± 6.67 | 68.68 ± 3.56 | 0.061 | 0.056 | 0.77 | 0.74 |
| 16 | 6.5 | 35 | 25 | 0.2 | 100:10 | 73.89 ± 3.82 | 69.85 ± 6.52 | 0.061 | 0.056 | 0.69 | 0.68 |
EN, Experiment number; Tem, Temperature (°C); Sal, Salinity (ppt); Optical density (OD600nm); C/N, Carbon/Nitrogen (molar).
Identification of bacterial isolates by 16S rDNA and their growth on Flu and Phe as the sole source of carbon
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| SBU1 |
| KF052989 | 9.2 | 9.9 | 9.6 | 14.3 |
| SBU2 |
| KF052990 | 2.6 | 10.6 | 20.6 | 26.0 |
| SBU3 |
| KF052991 | 0.0 | 1.5 | 0.0 | 7.8 |
| SBU4 | Unidentified | - | 5.1 | 3.7 | 6.4 | 15.5 |
| SBU5 | Unidentified | - | 5.3 | 8.9 | 3.0 | 3.8 |
| SBU6 | Unidentified | - | 0.0 | 8.6 | 9.7 | 11.0 |
| Mix of isolated strains | - | - | 16.7 | 21.4 | 21.3 | 24.1 |
| Enrichment consortium (SBU) | - | - | 64.0 | 58.4 | 59.9 | 40.8 |
Figure 1Concentrations of residual PAHs (trials 1-8) during 20 days experiment with the inoculation of enriched consortium (Flu: dark bar, Phe: light bar).
Figure 2Concentrations of residual PAHs (trials 9-16) during 20 days experiment with the inoculation of enriched consortium (Flu: dark bar, Phe: light bar).
Results of S/N ratio comparisons based on the values of the first order rate constants (k) and biodegradation percentages at the end of the 20-day experiment
|
|
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| pH | 72.93 | 0.00 | 0.0144 | 27.16 | 0.00 | 0.0214 | 52.69 | 0.00 | 9.70 | 21.52 | 0.00 | 11.86 |
| Temperature | 70.98 | 0.00 | 0.0145 | 19.20 | 0.00 | 0.0178 | 53.04 | 0.00 | 9.80 | 14.54 | 0.00 | 10.66 |
| Inoculum | 58.79 | 0.00 | 0.0165 | 9.05 | 0.00 | 0.0138 | 57.99 | 0.00 | 11.09 | 15.34 | 0.00 | 9.66 |
| Salinity | 15.91 | 0.00 | 0.0092 | 7.37 | 0.00 | 0.0161 | 9.98 | 0.00 | 4.36 | 3.67 | 0.02 | 5.73 |
| C/N | 16.24 | 0.00 | 0.0082 | 5.49 | 0.00 | 0.0118 | 15.50 | 0.00 | 4.98 | 4.79 | 0.00 | 5.48 |
Figure 3Comparison of Flu (right) and Phe (left) biodegradation efficiency between predicted optimized conditions based on the values of the biodegradation percentages (a) or first order rate constants (b) and Taguchi trial 4 (c).